Market Samachar
CNBC
·
GLOBAL
·
Weight loss drug maker sinks 25% after new safety data spooks investors
As reported by CNBC
While the experimental drug met its key targets, analysts are concerned over the commercial opportunity due to side effects.
▸ MARKET SAMACHAR VIEW
NEUTRAL
Read full article on CNBC ↗
Market Samachar is a news aggregator. This article was originally published by
CNBC. Tap the button above to read the full story on their site.
🔥 Hot Now
Top stories across markets in the last hour
More from Market Samachar